One of the top hospitals for breast cancer treatment in Tamil Nadu is the Hospitals in Chennai. With a dedicated breast cancer clinic, it offers comprehensive care including advanced diagnostics, surgery, chemotherapy, and radiation therapy. The hospital boasts a team of experienced oncologists, sur

3 views • 4 slides

Globally, cervical cancer is the fourth most common cancer in women, with 6,04,000 new cases in 2020. Women living with HIV are 6 times more likely to develop cervical cancer, compared to the general population, and an estimated 5% of all cervical cancer cases are attributable to HIV. The contributi

2 views • 7 slides

The Fred & Pamela Buffett Cancer Center offers a Training Navigator Program aimed at meeting Nebraska's cancer research education needs, addressing disparities, and guiding scholars in the pathway of cancer-related research training. The program focuses on facilitating career development, networking

0 views • 30 slides

The training programme for officers of the Government of NCT of Delhi focused on the need, infrastructure, constraints, and possible solutions related to cancer care. With increasing cancer burden and high mortality rates, Delhi faces challenges in early detection, high treatment costs, and maintain

0 views • 25 slides

The Canadian Cancer Research Alliance (CCRA) is a collaboration of organizations funding cancer research in Canada to advance prevention, diagnosis, and treatment. Established in 2005, CCRA has grown to over 35 members and published strategic plans to enhance cancer research outcomes. The Alliance s

1 views • 40 slides

Pioneering cancer nurses in Europe are driving advancements in cancer care through innovative approaches, evidence-based knowledge, and personalized patient-centered care. They play a vital role in cancer prevention, healthcare policy enhancement, and education improvement. By putting patients and f

0 views • 12 slides

Did you know that seeking a second opinion from an experienced cancer specialist in Pune could be the key to unlocking more effective cancer treatment options? When you are diagnosed with cancer and researching about the treatment options then you must take a second opinion for your treatment for be

1 views • 3 slides

The Europe Cancer Diagnostics Market is projected to reach $12.21 billion by 2031, at a CAGR of 5.6% during the forecast period 2024\u20132031. The Europe cancer diagnostics market is driven by the rising prevalence of cancer, supporting initiatives for early cancer diagnosis, increasing investments

3 views • 4 slides

Cancer care in India is undergoing a paradigm shift with the introduction of a new immunotherapy treatment: Dostarlimab. This potent formulation (7.5 mg\/5 ml) promises to change the treatment paradigm for oncologists as well as patients fighting cancer. Dostarlimab 7.5 mg\/5 ml is a revolutionary i

5 views • 7 slides

Breast cancer is the most common cancer among women around the globe. However, in comparison to the developed nations, India\u2019s cancer incidence is far lower. Nevertheless, the death rates are still higher due to late detection.

1 views • 3 slides

The Canadian Cancer Statistics 2023 report provides a comprehensive analysis of cancer data, including trends, statistics, and insights for the year. The report covers various aspects of cancer, such as incidence rates, survival rates, types of cancers diagnosed, and advancements in cancer treatment

0 views • 31 slides

SWAG Network Brain & CNS Cancer Clinical Advisory Group provides research updates on national brain cancer recruitment, national vs. regional recruitment, and ongoing brain cancer studies in the SWAG region. Additionally, insights from the Cancer Patient Experience Survey 2021 shed light on patient

0 views • 10 slides

The Ontario Breast Screening Program (OBSP) is a quality-assured, population-based breast cancer screening initiative administered by Cancer Care Ontario. It aims to reduce breast cancer mortality through early detection by providing biennial screenings for average-risk women aged 50-74 and annual s

3 views • 21 slides

The Cancer Therapy Evaluation Program (CTEP) aims to enhance cancer patients' lives by advancing cancer treatment through research and clinical trials. The Program includes a Protocol and Information Office (PIO) to streamline trial development processes. It funds national cancer research and focuse

0 views • 27 slides

Translational Liver Consortia (TLC) and the Translational Hepatocellular Carcinoma Consortium (THCCC) led by Dr. Hashem B. El-Serag are focused on advancing research for early detection of liver cancer. The main objectives include patient stratification for liver cancer risk, surveillance in cirrhos

0 views • 25 slides

Apoptosis, a form of programmed cell death, is crucial for cellular homeostasis. In cancer, inhibition of apoptosis processes allows cancer cells to survive and proliferate abnormally. Developing targeted treatments for apoptosis pathways is essential for improved outcomes in cancer therapy. Cell de

2 views • 22 slides

Cancer patients undergoing anti-cancer therapy need vigilant monitoring for hyperglycemia. Baseline HbA1c and random plasma glucose levels must be checked before initiating therapy. Regular glucose monitoring, symptom assessment, and ketone testing are crucial throughout treatment. Prompt referrals,

0 views • 4 slides

Cancer Alliances play a crucial role in coordinating cancer care and improving outcomes for patients. The South West Lung Pathway Transformation focuses on implementing rapid assessment pathways for lung, prostate, and colorectal cancers. Their priorities include meeting waiting time standards, diag

0 views • 23 slides

Cancer nurses play a crucial role in raising awareness about effective cancer prevention methods, supporting the European Code Against Cancer, providing advice for risk reduction, promoting health literacy, and encouraging early diagnosis through screening programs. Their expertise and leadership ar

0 views • 30 slides

Melanoma, a type of skin cancer, can be life-threatening if not diagnosed early. This study presented at the IEEE EMBC conference focuses on using a convolutional neural network for automated detection of melanoma lesions in clinical images. The importance of early detection is highlighted, as exper

0 views • 34 slides

The Cancer Genome Atlas (TCGA) project, initiated in 2005, aims to identify genetic mutations in cancer through genome sequencing. Supervised by the Center for Cancer Genomics, TCGA has expanded over the years, publishing numerous research articles and involving various tumor types. The project has

0 views • 7 slides

Cancer survival rates in Europe have shown variations across different types of cancer and countries. While overall cancer mortality has increased over the years, some countries have experienced declines in mortality rates. Survival rates for breast cancer between 1995-2014 ranged from 74% to 89%, w

0 views • 17 slides

The Wessex RIS is a new cancer referral pathway aimed at patients with concerning non-specific symptoms. Working in partnership with acute trusts in Wessex, the service provides timely investigations to exclude cancer in such patients. Established as part of the National Rapid Diagnostic Centre proj

0 views • 15 slides

Exploring the concept of cancer health disparities, this content touches on the National Cancer Act of 1971, the impact of social determinants of health, and various initiatives such as the National Minority Cancer Awareness Week. It highlights efforts to reduce disparities through research, advocac

3 views • 8 slides

Normal cells undergo defined lifespan processes, but disruptions in cell differentiation and apoptosis can lead to cancer development. Unchecked cell growth caused by genetic mutations results in tumors that can metastasize. Cancer is a multistep disease involving genetic changes, and major transfor

4 views • 26 slides

Cancer is a disease characterized by the uncontrollable growth and spread of abnormal cells in the body. These cells form tumors that can be either cancerous (malignant) or non-cancerous (benign). Cancer can develop in various parts of the body and is often caused by genetic changes that affect cell

2 views • 21 slides

Results of the National Cancer Patient Experience Survey 2019 for Somerset, Wiltshire, Avon, and Gloucestershire Cancer Alliance were presented. The survey captured experiences of adults diagnosed with cancer who had received care from primary diagnosis to follow-up support. The report highlighted b

0 views • 16 slides

Breast cancer molecular subtypes play a crucial role in determining survival outcomes. This study by Nadia Howlader, PhD, from the National Cancer Institute, presented the first nationally representative estimates of breast cancer survival by four main molecular subtypes. The research aimed to under

1 views • 23 slides

Endometrial cancer, the most common gynecological malignancy in women, presents with abnormal uterine bleeding and affects women mainly during menopause. Risk factors include hormonal stimulation and estrogen levels. Differentiating between types of endometrial cancer can impact treatment decisions.

3 views • 31 slides

Data submission in cancer registry systems serves the purpose of contributing to a larger pool of information for monitoring cancer trends, determining patterns, guiding program planning, and assisting public health professionals. Organizations like the State Central Cancer Registries and national p

0 views • 11 slides

This collaborative project aims to utilize circulating autoantibody biomarkers for the early detection of ovarian cancer, highlighting the importance of screening due to the high curability rates in early stages and the need to improve survival rates by identifying preclinical disease sooner. The pr

3 views • 31 slides

Recent studies have shown advancements in anticoagulation therapy for cancer patients with venous thromboembolism (VTE) and stroke prevention. Direct oral anticoagulants (DOACs) are now considered beneficial for treating VTE in cancer, offering advantages in administration and efficacy. Different an

2 views • 9 slides

Liverpool Health Partners (LHP) Cancer Programme led by Prof. Andrew Pettitt and Dr. Matina Tsalavouta aims to reduce cancer incidence and mortality, improve patient quality of life, and align with the One Liverpool strategy. The comprehensive strategy focuses on inclusive consultation, engagement,

2 views • 13 slides

The Cancer Transformation Funding Alliance aims to enhance cancer care services by implementing Holistic Needs Assessments, Health & Wellbeing events, and Risk Stratified Pathways for different cancer sites. The program also focuses on developing Cancer Support Workers, improving data collection sys

0 views • 5 slides

Understanding the factors that influence the recall rate in mammography is crucial for improving the accuracy of breast cancer detection. This includes the impact of imaging technologies like digital mammography, human physical parameters, expertise of readers, and patient characteristics. The use o

0 views • 17 slides

The Humber, Coast and Vale Cancer Alliance's Cancer Champions Programme, led by Trish Rawnsley, aims to raise awareness and promote early diagnosis of cancer. Developed in North East Lincolnshire in 2011, the program has trained almost 1,000 individuals, resulting in lower emergency presentations in

0 views • 10 slides

Half of people born since 1960 in London and West Essex will be diagnosed with cancer in their lifetime, highlighting the pressing need to address cancer care inequalities. The Transforming Cancer Services Team has developed a comprehensive strategy to reduce these disparities and improve outcomes t

0 views • 55 slides

Cancer registries serve as vital information systems for collecting, storing, and analyzing cancer data to aid in research, prevention, treatment, and public health efforts. They help track cancer incidence, assist in identifying trends, and provide essential information to healthcare professionals

0 views • 18 slides

Activities focusing on standardizing cancer care in Europe include quality assurance of screening programs, defining survivorship, establishing Comprehensive Cancer Control Networks, addressing socio-economic inequalities, and promoting public health genomics. The European Cancer Patient Coalition e

0 views • 7 slides

GRANDproto project workshop held in May 2017 focused on improving autonomous radio detection efficiency for the detection of extensive air showers (EAS). Issues such as detector stability and background rates were discussed, with the goal of establishing radio detection as a reliable method for EAS

0 views • 14 slides